Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
Next Article Previous Article
- Wyden Exposes Private Placement Life Insurance as a Tax Shelter for the Ultra-Wealthy Holding at Least $40 Billion
- Wyden Statement on Social Security Proposed Rule to Reduce Overpayments
- Wyden Welcomes First Step in Implementation of Organ Transplant Law
- Wyden Urges President Biden to Remove Social Security Watchdog
- Wyden Statement at Finance Committee Hearing on AI in Health Care